Psilocybin and mental health: uses, evidence and legality

Psilocybin —the main psychoactive compound in so-called “magic mushrooms”— has become one of the most researched molecules in mental health. Leading centres are studying its potential for depression, anxiety and addiction, and the U.S. FDA has granted it “breakthrough therapy” designation. In this guide we look at psilocybin and mental health: how it works, what the evidence says, its legal status in Spain in 2026 and why the therapeutic context is decisive.

What is psilocybin and how does it work in the brain?

Psilocybin is a natural substance found in more than 200 species of mushrooms. In the body it is converted into psilocin, which acts as an agonist of the serotonin 5-HT2A receptors. That activation reduces the activity of the default mode network (the network linked to rumination and mental “autopilot”) and transiently increases connectivity and neuroplasticity between brain regions. Many researchers believe this “window” of greater brain flexibility is what allows rigid emotional patterns to be revisited when paired with psychotherapy.

What does the scientific evidence say?

Research over the last decade points to several promising uses, all still under study:

• Treatment-resistant depression: controlled clinical trials have shown significant symptom reductions after one or two sessions with supportive psychotherapy, with effects that can last for weeks.
• Anxiety and depression linked to serious illness: in cancer patients, psilocybin has shown sustained improvements in mood and acceptance.
• Addiction: preliminary studies in smoking and alcohol use disorder show encouraging results.

Caution is warranted: most are studies with small samples under highly controlled conditions. Psilocybin is not approved as a general-use medicine; its efficacy and safety depend on the clinical setting. Australia has allowed supervised prescribing since 2023 and some U.S. states (Oregon, Colorado) permit its use in supervised settings, but these are regulated exceptions.

Is psilocybin legal in Spain? (2026)

In Spain, psilocybin and psilocin are listed as controlled substances: their production, sale and possession for unauthorised purposes are illegal. It is not approved as a medicine and its use is restricted to authorised research. In other words, there is currently no legal psilocybin treatment available to the general public in Spain. Any information about its therapeutic potential refers to clinical studies, not to an available or self-administered practice.

Why context is almost everything: set, setting and integration

One idea recurs throughout psychedelic research: the effect depends not only on the molecule, but on the “set” (the person’s mindset and expectations) and the “setting” (the environment and support). That is why trials combine the substance with preparation, support during the session and later integration in psychotherapy. Without that framework, risks increase and the potential benefit fades.

Risks and contraindications

Psilocybin has a relatively favourable physiological safety profile, but it is not harmless. It can cause intense anxiety, confusion or difficult experiences (“bad trips”), and is contraindicated in people with a history of psychosis or certain psychiatric disorders, because of the risk of triggering episodes. Interactions with other drugs (such as some antidepressants) must also be assessed. Recreational or independent use, outside a clinical framework, carries real risks.

Psilocybin and psychedelics at Fuertedélica

At Fuertedélica, the international conference on psychedelics and mental health, we dedicate space to the science of psilocybin and its place in the future of mental health. If you are interested in professional practice, see our training for therapists. You may also want to read our complete guide to ketamine-assisted therapy (KAP).

Frequently asked questions

Does psilocybin cure depression?

We don’t talk about a “cure”. Some trials show rapid and sometimes lasting symptom reductions, especially in treatment-resistant depression, but always within a clinical framework with psychotherapy. It is not an approved treatment or available to the general public.

How long do the effects of psilocybin last?

A psilocybin experience usually lasts 4 to 6 hours, depending on the dose. The potential therapeutic benefits being studied are linked to later integration, not just the session itself.

Is psilocybin legal in Spain?

No. In Spain it is a controlled substance, not approved as a medicine, and its use is limited to authorised research.

Is psilocybin the same as microdosing?

Not exactly. Microdosing means taking very low, sub-perceptual doses; the scientific evidence on its benefits is still limited and mixed, in contrast to the high doses used in clinical trials with psychotherapy.

This article is for informational purposes and does not constitute medical advice or an invitation to use. Psilocybin is a controlled substance in Spain. If you are going through a mental health situation, consult a qualified healthcare professional.